Search Results for Clinical Trials
Your search produced 28 clinical trials for breast.View the clinical trial details for a full description of the study.
|
A Clinical Trial Comparing 16-18 Weeks of daily Exemestane, Letrozole, or Anastrozole in Postmenopausal Women with Stage II and III Estrogen Receptor Positive Breast Cancer (ACOSOG Z1031)
Currently enrolling additional patients: Yes Clinical Trial Details |
|
Dose-Dense Adjuvant Chemotherapy plus Bevacizumab in Lymph Node Positive Breast Cancer: a Pilot Study (421-07)
Currently enrolling additional patients: Yes Clinical Trial Details |
|
A Phase I/II Clinical Trial Assessing Safety and Efficacy of BZL101 for Metastatic Breast Cancer (425-07)
Currently enrolling additional patients: Yes Clinical Trial Details |
|
Intact Percutaneous Excision Trial: A Multi-center Clinical Study of the Intact Breast Lesion Excision System (BLES) to Demonstrate that a Definitive Diagnosis can be made from the Tissue Sample Collected with the Intact BLES (446-07)
Currently enrolling additional patients: Yes Clinical Trial Details |
|
A Randomized Trial Comparing Treatment with Pegylated Liposomal Doxorubicin or Capecitabine as Initial Chemotherapy for Metastatic Breast Cancer in Women 60 Years and Older (265-05)
Currently enrolling additional patients: Yes Clinical Trial Details |
|
A Trial of Two Schedules of Perifosine in Subjects with Breast Cancer for whom No Standard Therapy Exists (256-05)
Currently enrolling additional patients: Yes Clinical Trial Details |
|
A Trial of Biphosphonates as Adjuvant Therapy for Primary Breast Cancer (SWOG S0307)
Currently enrolling additional patients: Yes Clinical Trial Details |
|
A Phase III Study of SU011248 in Combination with Paclitaxel vs, Bevacizumab with Paclitaxel as First Line Treatment for Patients with Advanced Breast Cancer (475-07)
Currently enrolling additional patients: Yes Clinical Trial Details |
|
A Study to Evaluate the Long-term Impact of Identifying Tumor-draining Lymph Nodes using Lymphoseek in Patients with known Melanoma or Breast Cancer (529-08s)
Currently enrolling additional patients: Yes Clinical Trial Details |
|
A Double-Blind Study of Sorafenib compared to Placebo when given with Chemotherapy for Subjects with Locally Advanced or Metastatic Breast Cancer that has Progressed during or after Bevacizumab Therapy (471-07)
Currently enrolling additional patients: Yes Clinical Trial Details |
|
A Trial Comparing Anastrozole and Tamoxifen in Postmenopausal Patients with Breast Cancer (Ductal Cancer in Situ) who are undergoing Lumpectomy and Radiation Therapy (NSABP B-35)
Currently enrolling additional patients: Yes Clinical Trial Details |
|
A Phase III Study of Neoadjuvant Therapy in Patients with Operable Breast Cancer, Attempting to Identify Predictors of the Likelihood of a Clinical Response to each Regimen (NSABP B-40)
Currently enrolling additional patients: Yes Clinical Trial Details |
|
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer. (NSABP P-2)
Currently enrolling additional patients: Yes Clinical Trial Details |
|
A Randomized Trial of Neoadjuvant Therapy for Patients with Palpable and Operable HER2-Positive Breast Cancer, with Correlative Studies to Identify Predictors of Pathologic Complete Response. (NSABP-41)
Currently enrolling additional patients: Yes Clinical Trial Details |
|
A Prospective Open-Label Comparison of Lymphoseek and Vital Blue Dye as Lymphoid Tissue Targetting Agents in Patients with known Melanoma or Breast Cancer who are Undegoing Lymph Node Mapping (517-08s)
Currently enrolling additional patients: Yes Clinical Trial Details |
|
GeneSearch Breast Lymph Node Assay for Intraoperative Molecular Testing (223-04s)
Currently enrolling additional patients: No Clinical Trial Details |
|
A Multicenter, Phase III, Randomized, Placebo-Controlled Trial Evaluating the Efficacy and Safety of Bevacizumab in Combination with Chemotherapy Regimens in Subjects with Previously Untreated Metastatic Breast Cancer (317-05)
Currently enrolling additional patients: No Clinical Trial Details |
|
An Open-label Study of IV RPR109881 in patients with Metastatic Breast Cancer, after Treatment with standard Therapies (anthracyclines, taxanes and capecitabine) (217-04)
Currently enrolling additional patients: No Clinical Trial Details |
|
High Dose Chemotherapy for Young Women with High Risk Breast Cancer. (063-97)
Currently enrolling additional patients: No Clinical Trial Details |
|
McGhan Medical Style 410 Silicone-Filled Breast Implant Clinical Study. (057-01)
Currently enrolling additional patients: No Clinical Trial Details |
|
A Retrospective review of Bevacizumab (Avastin) and Albumin Bound Paclitaxel (Abraxane) Treatment in Metastatic Breast Cancer (392-06CR)
Currently enrolling additional patients: No Clinical Trial Details |
|
Fertility Drugs and Ovarian, Endometrial, and Breast Cancer: A Multi-Institutional Study (044-95)
Currently enrolling additional patients: No Clinical Trial Details |
|
A Randomized Study Comparing rhe Combination of Pazonib AND Lapatinib vs. Lapatinib ALONE is Patients with certain types of Inflammatory Breast Cancer (469-07)
Currently enrolling additional patients: No Clinical Trial Details |
|
A Trial Comparing Docetaxel in Combination with Doxorubicin and Cyclophosphamide (TAC) vs. Doxorubicin and Cyclophosphamide Followed by Docetaxel (AC-T) as Adjuvant Treatment of Operable Breast Cancer Patients with Positive Axillary Lymph Nodes. (BCIRG 005)
Currently enrolling additional patients: No Clinical Trial Details |
|
A Randomized Trial Comparing Preoperative Doxorubicin (Adriamycin) Cyclophosphamide (AC) to Preop AC Followed by Preop Docetaxel (Taxotere) and to Preop AC Followed by Postop Docetaxel in Patients With Operable Carcinoma of the Breast (NSABP B-27)
Currently enrolling additional patients: No Clinical Trial Details |
|
A Trial in Post-menopausal Women with Hormone Receptor Positive Breats Cancer to Determine the Effectiveness of Letrozole compared to Placebo when given for 5 years to Subjects who have Completed 5 years of Therapy with Tamoxifen followed by an Aromatase (NSABP B-42)
Currently enrolling additional patients: No Clinical Trial Details |
|
Phase III Comparison of Adjuvant Chemotherapy With or Without Endocrine Therapy in High-Risk, Node-Negative Breast Cancer Patients, and a Natural History Follow-up Study in Low-Risk, Node-Negative Patients (SWOG 8897)
Currently enrolling additional patients: No Clinical Trial Details |
|
A Study of Sunitinib Malate as a Single Agent for the Treatment of Women with Advanced Breast Cancer. (468-07)
Currently enrolling additional patients: No Clinical Trial Details |
